Veterinary Medicines

CATTLEMASTER 4

Authorised
  • Bovine viral diarrhoea virus 1, strain 5960, Inactivated
  • Bovine parainfluenza virus 3, strain RLB103, Live
  • Bovine viral diarrhoea virus 1, strain 6309, Inactivated
  • Bovine respiratory syncytial virus, strain 375, Live
  • Bovine herpesvirus 1, strain RLB 106, Live
Download as PDF

Product identification

Medicine name:
CATTLEMASTER 4
Active substance:
  • Bovine viral diarrhoea virus 1, strain 5960, Inactivated
  • Bovine parainfluenza virus 3, strain RLB103, Live
  • Bovine viral diarrhoea virus 1, strain 6309, Inactivated
  • Bovine respiratory syncytial virus, strain 375, Live
  • Bovine herpesvirus 1, strain RLB 106, Live
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine viral diarrhoea virus 1, strain 5960, Inactivated
    0.31
    millilitre(s)
    /
    1.00
    unit(s)
  • Bovine parainfluenza virus 3, strain RLB103, Live
    5.00
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)
  • Bovine viral diarrhoea virus 1, strain 6309, Inactivated
    0.62
    millilitre(s)
    /
    1.00
    unit(s)
  • Bovine respiratory syncytial virus, strain 375, Live
    4.10
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)
  • Bovine herpesvirus 1, strain RLB 106, Live
    5.70
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AH
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Italia S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 1/11/2024
Download